Simmonds H A, Levinsky R J, Perrett D, Webster D R
Biochem Pharmacol. 1982 Mar 15;31(6):947-51. doi: 10.1016/0006-2952(82)90325-2.
A reciprocal relationship between erythrocyte ATP and deoxy-ATP levels has been noted in an immunodeficient child with adenosine deaminase (ADA) deficiency during therapy with red cell transfusions. The sum of red cell ATP plus deoxy-ATP equalled the normal complement of ATP prior to any form of therapy. dATP, dADP and dAMP levels were found in the same ratio (10:1:0.1) as the adenine nucleotides ATP, ADP and AMP. Red cell ATP levels were low, not high or normal as found by others in ADA deficiency, but no deoxyadenosine nucleotides could be found in peripheral blood mononuclear cells. Erythrocyte ATP depletion has recently been identified as a serious consequence of anti-leukaemic therapy with ADA inhibitors; it may thus be an important but hitherto unrecognised contributing factor in the clinical expression of inherited ADA deficiency.
在一名腺苷脱氨酶(ADA)缺乏的免疫缺陷儿童接受红细胞输血治疗期间,已注意到红细胞ATP和脱氧ATP水平之间存在相互关系。在任何形式的治疗之前,红细胞ATP加脱氧ATP的总和等于ATP的正常含量。发现dATP、dADP和dAMP水平与腺嘌呤核苷酸ATP、ADP和AMP的比例相同(10:1:0.1)。红细胞ATP水平较低,不像其他人在ADA缺乏症中发现的那样高或正常,但在外周血单核细胞中未发现脱氧腺苷核苷酸。红细胞ATP耗竭最近被确定为使用ADA抑制剂进行抗白血病治疗的严重后果;因此,它可能是遗传性ADA缺乏症临床表型中一个重要但迄今未被认识到的促成因素。